1-4 of 4
Kojo S. J. Elenitoba-Johnson, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCL10 Gain-of-Function Mutations Aberrantly Induce Canonical and Non-Canonical NF-Kb Activation and Resistance to Ibrutinib in ABC-DLBCL

Min Xia, Liron David, PhD, Matthew Teater, PhD, Ozlem Onder, PhD MSc, Kojo S. J. Elenitoba-Johnson, MD, Lorena Fontan, PhD, Hao Wu, PhD, Ari Melnick, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-141363
Published: 2020
Journal Articles

Epigenetic Modulation of CD48 By NPM-ALK Promotes Immune Evasion in ALK+ ALCL

Rui Wu, MD PhD, Elena Ivan, MD, Anagh Anant Sahasrabuddhe, PhDMSc,BSc, Timothy Shaw, PhD, Charles G. Mullighan, MBBS, MD, Vasiliki Leventaki, Kojo S. J. Elenitoba-Johnson, MD, Megan S. Lim, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1510.
https://doi.org/10.1182/blood-2019-127453
Published: 2019
Journal Articles

Integrated Phosphoproteomic and N-Glycoproteomic Landscape of Cutaneous T-Cell Lymphoma Reveals Distinctive Pathogenetic Insights and Therapeutic Vulnerabilities

John Simon Van Arnam, MD MS, Delphine C. M. Rolland, PharmD, PhD, Kojo S. J. Elenitoba-Johnson, MD, Megan S. Lim, MDPhD, Özlem Önder, PhD, Nathanael G. Bailey, MD, David Bahler, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2763.
https://doi.org/10.1182/blood.V130.Suppl_1.2763.2763
Published: 2017
Journal Articles

NPM1-TYK2 Fusion Is an Oncogene and a Novel HSP90-Client Protein

Sudhakiranmayi Kuravi, M.S., Preethi Kunchala, M.S., Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Yogen Saunthararajah, MD, Kojo S. J. Elenitoba-Johnson, MD, Jensen Roy, MD, Joseph McGuirk, DO, Ramesh Balusu, PhD
Journal: Blood
Blood (2016) 128 (22): 4127.
https://doi.org/10.1182/blood.V128.22.4127.4127
Published: 2016